open access
QTc prolongations as a result of drug interactions of CD4/6 inhibitors
- Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Krakow, Poland
- Department of Coronary Disease and Heart Failure, Jagiellonian University Medical College, John Paul II Hospital, Krakow, Poland
open access
Abstract
Abstract
Title
QTc prolongations as a result of drug interactions of CD4/6 inhibitors
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Pictures in Oncology
Pages
258
Published online
2022-05-25
Page views
3891
Article views/downloads
324
DOI
Bibliographic record
Nowotwory. Journal of Oncology 2022;72(4):258.
Authors
Aleksandra Grela-Wojewoda
Mirosława Puskulluoglu
Joanna Lompart
Marek Ziobro
Ewa Konduracka
- Grela-Wojewoda A, Pacholczak-Madej R, Adamczyk A, et al. Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer. Int J Mol Sci. 2022; 23(5): 2815.
- Rascon K, Flajc G, De Angelis C, et al. Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients. Ann Pharmacother. 2019; 53(5): 501–509.